Lenalidomide for the salisbury VAMC, charlotte HCC, and kernersville HCC.

Active Awarded Last action

Contract number
36C24626N0410
Awardee
Awarding agency
Obligated
$5,146,882

Award facts

Contract value 100% obligated
$5,146,882.12 Current and potential, with all options
Completion date 76% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boca Raton, FL 33432, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a firm fixed-price delivery order valued at $5.15M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to the Salisbury VA Medical Center, Charlotte Health Care Center, and Kernersville Health Care Center. The contract, which carries no set-aside designation, was awarded on January 15, 2026, with an ultimate completion date of January 14, 2027. Lenalidomide is an immunomodulatory agent used to treat oncologic and hematologic malignancies within the VA healthcare system. This delivery order operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which provides the contracting framework for pre-competed pharmaceutical procurement across federal agencies.

Exelan Pharmaceuticals, headquartered in Boca Raton, Florida, serves as a critical supplier to the VA and other federal healthcare systems, specializing in the manufacturing, repackaging, and distribution of generic and branded pharmaceutical products. The company maintains an extensive portfolio of indefinite delivery contracts and blanket purchase agreements with the VA National Acquisition Center and Defense Logistics Agency, with individual contract vehicles exceeding $88M in ceiling value. Exelan performs substantially all work at its Boca Raton facility and operates primarily as a prime contractor without major identified subcontractors. The company competes on an unrestricted, fully open basis across its federal pharmaceutical supply portfolio.

Quick answers

Who was awarded contract 36C24626N0410?

36C24626N0410 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.

How much is contract 36C24626N0410 worth?

The government has obligated $5,146,882 on 36C24626N0410.

Is contract 36C24626N0410 an order under another contract?

Yes. 36C24626N0410 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24626N0410 competed?

The extent of competition for 36C24626N0410 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award